Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as a new oral delivery of two GLP-1 drugs previously approved by the FDA in injectable form.
Mar 4, 2026
0
2
Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way for the body to make its own weight-loss drugs, doing away with injections in favor of ...
Jul 9, 2025
0
7
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.
Feb 4, 2025
0
42
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the risk of death, stroke ...
Nov 18, 2024
0
0
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use.
Nov 15, 2024
0
0
Patients with "blinding" headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found.
Mar 13, 2023
0
44
Research shows an innovative model of care that includes a weekly nurse review and an injection of a drug known as Exenatide-LAR significantly improves sugar management for Indigenous Australians with type 2 diabetes (T2D) ...
Sep 26, 2022
0
4
